½ÃÀ庸°í¼­
»óǰÄÚµå
1812400

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

Remote Patient Monitoring Devices Market

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Transparency Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 161 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå - Á¶»ç ¹üÀ§

TMRÀÇ Á¶»ç º¸°í¼­ '¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå'Àº 2025-2035³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ÁöÇ¥¿¡ ´ëÇÑ °¡Ä¡ ÀÖ´Â ÀλçÀÌÆ®¸¦ ¾ò±â À§ÇØ °ú°Å ¹× ÇöÀçÀÇ ¼ºÀå µ¿Çâ°ú ±âȸ¸¦ ¿¬±¸ÇÕ´Ï´Ù. º» º¸°í¼­´Â 2025³âÀ» ±âÁØ ¿¬µµ, 2035³âÀ» ¿¹Ãø ¿¬µµ·Î ¼³Á¤ÇÏ¿© ¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¼öÀͰú ¿¹ÃøÀ» Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ 2025-2035³â ¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)µµ Á¦°øÇÕ´Ï´Ù.

º» º¸°í¼­´Â ±¤¹üÀ§ÇÑ Á¶»ç¸¦ °ÅÃÄ ÀÛ¼ºµÇ¾ú½À´Ï´Ù. 1Â÷ Á¶»ç¿¡¼­ ºÐ¼®°¡µéÀº KOL(Key Opinion Leader), ¾÷°è ¸®´õ ¹× ÀÇ°ß Çü¼ºÀÚµé°úÀÇ ÀÎÅͺ並 ¼öÇàÇÏ´Â µî ¿¬±¸ ³ë·ÂÀÇ ´ëºÎºÐÀ» Â÷ÁöÇß½À´Ï´Ù. 2Â÷ ¿¬±¸´Â ÁÖ¿ä ¾÷üµéÀÇ Á¦Ç° ¹®Çå, ¿¬Â÷ º¸°í¼­, º¸µµ ÀÚ·á ¹× °ü·Ã ¹®¼­¸¦ ÂüÁ¶ÇÏ¿© ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» ÆÄ¾ÇÇß½À´Ï´Ù.

½ÃÀå ÇöȲ
½ÃÀå ¸ÅÃâ(2024³â) 118¾ï ´Þ·¯
½ÃÀå ¸ÅÃâ(2035³â) 527¾ï ´Þ·¯
CAGR 14.4%

º» º¸°í¼­´Â ¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå °æÀï ±¸µµ¸¦ Á¶»çÇß½À´Ï´Ù. ¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÌ È®ÀÎµÇ°í °¢ ±â¾÷Àº ´Ù¾çÇÑ ¼Ó¼ºÀ¸·Î ÇÁ·ÎÆÄÀÏ ¸µµË´Ï´Ù. ±â¾÷ °³¿ä, À繫 »óȲ, ÃÖ±Ù ½ÃÀå °³Ã´ µ¿Çâ, SWOT´Â º» º¸°í¼­¿¡ ¼Ò°³µÈ ¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå Âü¿© ±â¾÷ ¼Ó¼ºÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÀüÁ¦Á¶°Ç°ú Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à : ¼¼°è ½ÃÀå

Á¦4Àå ½ÃÀå °³¿ä

  • ¼Ò°³
  • °³¿ä
  • ½ÃÀå ¿ªÇÐ
  • ¼¼°èÀÇ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ºÐ¼®°ú ¿¹Ãø(2020-2035³â)

Á¦5Àå ÁÖ¿ä ÀλçÀÌÆ®

  • ±â¼úÀû Áøº¸
  • ÁÖ¿ä Áö¿ª ¹× ±¹°¡ ±ÔÁ¦ ½Ã³ª¸®¿À
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • ½Å±Ô ½ÃÀå Âü°¡ÀÚ¸¦ À§ÇÑ ½ÃÀå °³Ã´ Àü·«

Á¦6Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : À¯Çüº°

  • ¼Ò°³ ¹× Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú ¹× ¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : À¯Çüº°(2020-2035³â)
    • ¸ÖƼÆÄ¶ó¹ÌÅÍ ¸ð´ÏÅ͸µ
    • È£Èí ¸ð´ÏÅ͸µ
    • Ç÷´ç ¸ð´ÏÅ͸µ
    • ½ÉÀå ¸ð´ÏÅ͸µ
    • ±âŸ
  • ½ÃÀå ¸Å·Â ºÐ¼® : À¯Çüº°

Á¦7Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ¿ëµµº°

  • ¼Ò°³ ¹× Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú ¹× ¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : ¿ëµµº°(2020-2035³â)
    • Á¾¾çÇÐ
    • ´ç´¢º´
    • ½ÉÇ÷°ü Áúȯ
    • ±âŸ
  • ½ÃÀå ¸Å·Â ºÐ¼® : ¿ëµµº°

Á¦8Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³ ¹× Á¤ÀÇ
  • ÁÖ¿ä Á¶»ç °á°ú ¹× ¹ßÀü
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : ÃÖÁ¾ »ç¿ëÀÚº°(2020-2035³â)
    • º´¿ø ¹× Áø·á¼Ò
    • ÀçÅà ÇコÄɾî ȯ°æ
    • ±âŸ
  • ½ÃÀå ¸Å·Â ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦9Àå ¼¼°è ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

  • ÁÖ¿ä Á¶»ç °á°ú
  • ½ÃÀå ¸ÅÃâ ¿¹Ãø : Áö¿ªº°(2020-2035³â)
    • ºÏ¹Ì
    • À¯·´
    • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ¶óƾ¾Æ¸Þ¸®Ä«
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • ½ÃÀå ¸Å·Â ºÐ¼® : Áö¿ªº°

Á¦10Àå ºÏ¹Ì ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦11Àå À¯·´ ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦12Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦13Àå ¶óÆ¾¾Æ¸Þ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦14Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ½ÃÀå ºÐ¼®°ú ¿¹Ãø

Á¦15Àå °æÀï ±¸µµ

  • ½ÃÀå ±â¾÷ : °æÀï ¸ÅÆ®¸¯½º(±â¾÷ µî±Þº°, ±Ô¸ðº°)
  • ½ÃÀå Á¡À¯À² ºÐ¼® : ±â¾÷º°(2024³â)
  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Omron Corporation
    • Koninklijke Philips NV
    • Welch Allyn
    • Abbott
    • Boston Scientific Corporation
    • Medtronic
    • Johnson & Johnson
    • Biotronik
    • Masimo
    • Nihon Kohden Corporation
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • MIR-Medical International Research
    • CareSimple Inc
HBR 25.09.29

Remote patient monitoring devices market- Scope of Report

TMR's report on the global Remote patient monitoring devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Remote patient monitoring devices market for the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Remote patient monitoring devices market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Remote Patient Monitoring Devices Market .

Market Snapshot
Market Value in 2024US$ 11.8 Bn
Market Value in 2035US$ 52.7 Bn
CAGR14.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Remote Patient Monitoring Devices Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Remote Patient Monitoring Devices Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Remote Patient Monitoring Devices Market .

The report delves into the competitive landscape of the global Remote Patient Monitoring Devices Market . Key players operating in the global Remote patient monitoring devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Remote patient monitoring devices market profiled in this report.

Key Questions Answered in Global Remote patient monitoring devices market Report:

  • What are the opportunities in the global Remote Patient Monitoring Devices Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Remote patient monitoring devices market- Research Objectives and Research Approach

The comprehensive report on the global Remote patient monitoring devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Remote patient monitoring devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Remote Patient Monitoring Devices Market .

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Remote Patient Monitoring Devices Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Remote Patient Monitoring Devices Market Analysis and Forecast, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Regulatory Scenario across Key Regions/Countries
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. PESTLE Analysis
  • 5.5. Supply Chain Analysis
  • 5.6. Go-to-Market Strategy for New Market Entrants

6. Global Remote Patient Monitoring Devices Market Analysis and Forecast, by Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Type, 2020 to 2035
    • 6.3.1. Multi-parameter Monitoring
    • 6.3.2. Respiratory Monitoring
    • 6.3.3. Blood Glucose Monitoring
    • 6.3.4. Cardiac Monitoring
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Type

7. Global Remote Patient Monitoring Devices Market Analysis and Forecast, by Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Application, 2020 to 2035
    • 7.3.1. Oncology
    • 7.3.2. Diabetes
    • 7.3.3. Cardiovascular Diseases
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Application

8. Global Remote Patient Monitoring Devices Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2020 to 2035
    • 8.3.1. Hospitals & Clinics
    • 8.3.2. Home Healthcare Settings
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Remote Patient Monitoring Devices Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2020 to 2035
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Remote Patient Monitoring Devices Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Type, 2020 to 2035
    • 10.2.1. Multi-parameter Monitoring
    • 10.2.2. Respiratory Monitoring
    • 10.2.3. Blood Glucose Monitoring
    • 10.2.4. Cardiac Monitoring
    • 10.2.5. Others
  • 10.3. Market Value Forecast, by Application, 2020 to 2035
    • 10.3.1. Oncology
    • 10.3.2. Diabetes
    • 10.3.3. Cardiovascular Diseases
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2020 to 2035
    • 10.4.1. Hospitals & Clinics
    • 10.4.2. Home Healthcare Settings
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Type
    • 10.6.2. By Application
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Remote Patient Monitoring Devices Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Type, 2020 to 2035
    • 11.2.1. Multi-parameter Monitoring
    • 11.2.2. Respiratory Monitoring
    • 11.2.3. Blood Glucose Monitoring
    • 11.2.4. Cardiac Monitoring
    • 11.2.5. Others
  • 11.3. Market Value Forecast, by Application, 2020 to 2035
    • 11.3.1. Oncology
    • 11.3.2. Diabetes
    • 11.3.3. Cardiovascular Diseases
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2020 to 2035
    • 11.4.1. Hospitals & Clinics
    • 11.4.2. Home Healthcare Settings
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. UK
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Switzerland
    • 11.5.7. The Netherlands
    • 11.5.8. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Type
    • 11.6.2. By Application
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Remote Patient Monitoring Devices Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Type, 2020 to 2035
    • 12.2.1. Multi-parameter Monitoring
    • 12.2.2. Respiratory Monitoring
    • 12.2.3. Blood Glucose Monitoring
    • 12.2.4. Cardiac Monitoring
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Application, 2020 to 2035
    • 12.3.1. Oncology
    • 12.3.2. Diabetes
    • 12.3.3. Cardiovascular Diseases
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2020 to 2035
    • 12.4.1. Hospitals & Clinics
    • 12.4.2. Home Healthcare Settings
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. South Korea
    • 12.5.5. Australia & New Zealand
    • 12.5.6. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Type
    • 12.6.2. By Application
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Remote Patient Monitoring Devices Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Type, 2020 to 2035
    • 13.2.1. Multi-parameter Monitoring
    • 13.2.2. Respiratory Monitoring
    • 13.2.3. Blood Glucose Monitoring
    • 13.2.4. Cardiac Monitoring
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Application, 2020 to 2035
    • 13.3.1. Oncology
    • 13.3.2. Diabetes
    • 13.3.3. Cardiovascular Diseases
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2020 to 2035
    • 13.4.1. Hospitals & Clinics
    • 13.4.2. Home Healthcare Settings
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Type
    • 13.6.2. By Application
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Remote Patient Monitoring Devices Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Type, 2020 to 2035
    • 14.2.1. Multi-parameter Monitoring
    • 14.2.2. Respiratory Monitoring
    • 14.2.3. Blood Glucose Monitoring
    • 14.2.4. Cardiac Monitoring
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Application, 2020 to 2035
    • 14.3.1. Oncology
    • 14.3.2. Diabetes
    • 14.3.3. Cardiovascular Diseases
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2020 to 2035
    • 14.4.1. Hospitals & Clinics
    • 14.4.2. Home Healthcare Settings
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Type
    • 14.6.2. By Application
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. Omron Corporation
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Koninklijke Philips N.V.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Welch Allyn
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Abbott
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Boston Scientific Corporation
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Medtronic
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Johnson & Johnson
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Biotronik
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Masimo
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Nihon Kohden Corporation
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. MIR - Medical International Research
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. CareSimple Inc
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦